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Abstract
Background: Prolonged P wave duration and P wave dispersion (PWD) have been associated 
with an increased risk for atrial fibrillation (AF). Hyperthytodism is a frequent cause of atrial 
fibrillation  (AF).                                                                                                   
Methods: Forty-two patients with newly diagnosed overt hyperthyroidism and 20 healthy people 
were enrolled in the study. Transthoracic echocardiography, 12 lead surface ECG and thyroid 
hormone levels were studied at the time of enrollment and after achievement of euthyroid state 
with propylthiouracil treatment.                                                                                     
Results: Maximum P wave duration (Pmax) (97.4±14.6 vs. 84.2±9.5 msec, p<0.001), PWD 
(42.9±10.7 vs. 31.0±6.2 msec, p<0.001), deceleration (DT) (190.7±22.6 vs. 177.0±10.2 msec, 
p=0.013) and isovolumetric relaxation times (IVRT) (90.9±11.2 vs. 79.6±10.5 msec, p<0.001) 
were significantly higher in hyperthyroid patients compared to control group. Pmax and PWD 
were significantly correlated  with the presence of hyperthyroidism.  Pmax  (97.4±14.6 to 
84.3±8.6 msec, p<0,001) Pmin (54.1±8.6 to 48.1±8.5 msec, p=0.002), PWD (42.9±10.7 to 
35.9±8.1 msec, p=0.002) and DT (190.7±22.6 to 185.5±18.3, p=0.036) were significantly 
decreased after achievement of euthyroid state in patients with hyperthyroidism. Diastolic 
dyfunction was seen in 5 patients at hyperthroid state but only in one patient at euthyroid state.  
Conclusions: Hyperthyroidism is associated with prolonged P wave duration and dispersion. 
Achievement of euthyroid state with propylthiouracil treatment results in shortening of P wave 
variables.   Diastolic function may have a partial effect for the increased Pmax and PWD. 
Shortening of Pmax and PWD may be a marker for the prevention of AF with the anti-thyroid 
treatment.
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Introduction
Hyperthyroidism has profound effects on the heart, including increased heart rate, slightly 
enhanced systolic function, left ventricular (LV) hypertrophy, and diastolic dysfunction [1-9]. 
Atrial fibrillation (AF) is the most common cardiac dysrhythmia in the adult population. 
Hyperthyroidism is a major cause of paroxysmal and latent atrial fibrillation (AF) [10-12] and 
AF,   after   the   sinus   tachycardia,   is   the   second   common   dysrhythmia   in   patients   with 
hyperthyroidism. Approximately in 10 – 15 % of hyperthyroid patients AF develop [13].     
P-wave duration and P-wave dispersion (PWD) are electrocardiographic (ECG) signs of 
prolongation of intraatrial and interatrial conduction time and inhomogeneous propagation of 
sinus impulses that are well known electrophysiological characteristics of the atrium prone to 
fibrillate [ 14-17].                                                                                                                              
In the present study, we aimed to evaluate P wave variables and LV diastolic function in 
hyperthyroid patients and to search the effects of shortterm propyl thio uracil (PTU) treatment. 
Materials and Methods                                                                                             
Forty two consecutive hyperthyroid  patients followed at out patient clinic of the endocrinology 
and metabolism department of the hospital and 20 healthy euthyroid healthy voluntary people 
were evaluated with 12-lead ECG and transthoracic echocardiography. Patients with systemic 
hypertension,   diabetes   mellitus,   history   of   structural   or   ischemic   heart   disease,   chronic 
obstructive pulmonary disease or any associated systemic disease and patients using systemic 
drugs, like steroids, antiarrythmics or antipsychotics, were excluded. The study was approved by 
the Yuzuncu Yil University, Faculty  of Medicine Ethics Committee in accordance with the 
Declaration of Helsinki. All participants were informed about the study and their consents were 
obtained.
In the patient group ECG and echocardiographic examinations were performed before treatment 
and after achievement  of euthyroid state with PTU treatment.                                 
Assessment of thyroid status                                                                                     
The evaluation of thyroid morphology and function was performed by clinical examination, 
assessment of serum free thyroid hormone T3 and T4 (FT3 and FT4) and throid stimulating 
hormone (TSH) levels, and ultrasound examination of the thyroid gland. A total of 5 ml of 
venous blood samples were drawn and then centrifuged at 2000 rpm for 10 min in a refrigerated 
centrifuge to separate serum. Serum FT3, FT4, TSH, levels were measured using the commercial 
Immulite  kits, which are solid-phase, two-site chemiluminescent  immunumetric assay in 
Immulite autoanalyser (IMMULITE, DPC, USA). The normal reference intervals were 0.80 – 
1.80 ng / dl, 1.8 – 4.2 pg/ ml and 0.40 – 4.0 mIU / ml for FT4, FT3 and TSH respectively.       
Echocardiographic  examination                                                                              
The echocardiographic examination was performed at rest, with the patient at left lateral 
decubitis position, using a commercially available echocardiographic device (Vivid 3, General 
Electric) with a 3 MHz transducer, by two experienced echocardiographers who were blinded to 
the clinical data. Using M-mode echocardiography, long-axis measurements were obtained at the 
level distal to the mitral valve leaflets according to current recommendations of the American 
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Society of Echocardiography [18].  The pulsed Doppler sampling volume was placed between 
the tips of the mitral valve leaflets to obtain maximum filling velocities. Early diastolic flow (E), 
atrial   contraction   signal   (A),   E/A   ratio   and   E   deceleration   time   (DT)   were   measured. 
Isovolumetric relaxation time (IVRT) was determined as the interval between the end of the 
aortic outflow and the start of the mitral inflow signal.                                                           
Tissue Doppler imaging (TDI) was acquired to assess diastolic function. The pulsed wave 
spectral mode was used for TDI. Filters and baselines were corrected when the velocity ranged 
between -20 and 20 cm/s. From the apical 4-chamber view, a 5-mm sample volume was placed 
at the lateral corner of the mitral annulus.  Early (Em) and late (Am) diastolic velocities were 
obtained. All values were measured on three separate beats and then averaged for all parameters. 
Impaired left ventricular relaxation was defined as having an E/A ratio of <1 (< 0.5 for >50 
years), DT > 200 msec and IVRT > 100 msec (>105 msec for >50 years), all together and/or 
E/Em ratio of >10 and Ea < 10 cm/sec in the presence of a preserved ejection fraction [19].         
Electrocardiographic assessment                                                                                                         
Twelve-lead ECGs were obtained at rest, with 20 mm/mV amplitude and 50 mm/sec rate with 
standard lead positions. ECGs were manually measured by the use of a magnifying glass by two 
blinded cardiologists having no information about the patients. The beginning of the P wave was 
defined as the point where the initial deflection of the P wave crossed the isoelectric line, and the 
end of the P wave was defined as the point where the final deflection of the P wave crossed the 
isoelectric line. The difference between maximum and minimum P wave duration was defined as 
PWD ( Figure 1). 
Figure 1: Two complexes extracted from 12-lead surface ECG of a patient with iron deficiency anemia. In this 
case, maximum P-wave duration was observed from lead aVF and the  minimum  P-wave duration from lead aVR. 
PWD was defined  as the difference between the maximum and minimum P-wave durations.
Intra-observer and inter-observer coefficients of variation for echocardiographic parameters and 
P wave variables were found to be less than 5% and nonsignificant.                                 
Statistical analysis                                                                                                     
Data were presented as mean ± standard deviation (SD). Using an SPSS package 10.0 (SPSS 
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Inc., Chicago, Illionis, USA) the changes of parameters after treatment were compared with 
paired t-tests. Differences in mean values between groups were assessed using the Student t test 
and with Mann-Whitney's U-test for variables without normal distribution. Pearson correlation 
analysis was used to assess the correlation between variables. A two-tailed p value < 0.05 was 
considered   significant.                                                                                  
Results
Maximum P wave duration, PWD, DT and IVRT were significantly higher in hyperthyroid 
patients compared to control group (Table 1). PWD was significantly correlated with presence 
of hyperthyroidism (r=0.501, p<0.001), IVRT (r=0.390, p=0.002), E/A (r=-0.350, p=0.005), DT 
(r=0.327, p=0.010), presence of diastolic dysfunction (r=0.298, 0.019) and age (r=0.255, 
p=0.045). Pmax was also significantly correlated with hyperthyroidism (r=0.404, p=0.001), age 
(r=0.270, p=0.034), E/A (r=-0.313, p=0.013), diastolic dysfunction (r=0.268, p=0.035), IVRT 
(r=0.265, p=0.038) and DT (r=0.259, p=0.042).  
Table 1: Comparison of baseline characteristics of hyperthytroid patients  with control group
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Euthyroid state was achieved during a 2,5±0,8 months. Pmax, Pmin, PWD and DT were 
significantly decreased after achievement of euthyroid state in patients with hyperthyroidism 
(Table 2, Figure 2). The slight decrease in IVRT was not significant. Diastolic dyfunction was 
observed in 5 patients at hyperthroid state but only in one patient at euthyroid state. 
Table 2: Comparison of pre- and post-treatment some echocardiographic values, thyroid 
hormones and P wave variables 
 
Figure 2: Error bar of pre- and post-treatment P wave dispersion (PWD), SE: Standard error
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Discussion
In this study we found that P maximum and PWD values were increased in hyperthyroidism and 
treatment with PTU results in improvement in Pmax, PWD and LV diastolic function parameters. 
The correlation between the presence of intraatrial conduction abnormalities and the induction of 
paroxysmal AF has been well documented [15,20]. P-wave dispersion has been advocated as a 
novel measurement of the heterogeneity of atrial depolarizations [21].  The increase in dispersion 
of atrial refractoriness may favor a re-entry mechanism leading to AF because fragmentation of 
the depolarizing wave  front may occur when it faces adjoining atrium with nonuniform 
refractoriness [21,22].  Accordingly, prolonged P-wave duration and increased PWD have been 
reported to carry an increased risk for AF [14,15].                                                     
Frequency   of   AF   is   increased   in   hyperthyroidism   [13].   The   cardiovascular   effects   of 
hyperthyroidism result from the increased metabolic demands of the body tissues and from the 
direct chronotropic and inotropic effects of excess thyroid hormone on the heart. Thyroid hormone 
alters the action potential duration and the speed of repolarization of atrial and ventricular 
myocytes  [23,24].   Thyroid  hormone  administration  shortens   action  potential   duration  and 
decreases the refractoriness of cardiomyocytes facilitating the maintenance of multiple reentrant 
circuits in hearts [25].                                                                                                 
Increase in Pmax and PWD values have been reported in hyperthyoidism [26]. Direct effects of 
thyroid hormones on ionic channels and action potential [23-25] and increased sympathetic 
activity [27,28] may be responsible fort this finding. Recent studies established the presence of 
prolonged P wave duration and P dispersion as markers of increased risk of AF in hyperthyroid 
subjects [14,16,29]. Treatment of hyperthyroidism is frequently associated with reversion to sinus 
rhythm. A recent study showed that reversion to sinus rhythm occurred in 62 percent of 163 
patients within 8-10 weeks after they returned to a euthyroid state [30]. Katircibasi et al [29] 
demonstrated that the prolonged P wave duration and dispersion recovered with PTU treatment  at 
levels measured in healthy control subjects. Our results supports these findings. Therefore, anti-
thyroid treatment may have preventive effects in the development of AF in patients with 
hyperthyroidism.  
Impaired left ventricular relaxation has been reported to effect PWD [31]. It has been reported that 
hyperthyrodism has profound effects on cardiac diastolic function that are at least in part 
reversible after restoration of euthyroidism [8,32-35]. In the present study, diastolic function 
parameters of DT and IVRT were increased in hyperthyroid state. In addition, diastolic function 
was normalized in 4 of 5 patients after achievement in euthyroid state. There were significant 
correlations between diastolic function and Pmax and PWD. Therefore, improvement in PWD in 
our study may be partially explained by improvement in diastolic function.                        
Limitations
Small number of study patients and short-term follow-up are the   major limitations. Another 
important limitation of our study is manual calculation of P-wave parameters using magnifying 
lens instead of computer-assisted P-wave calculations. We do not have automated measurement 
facilities for PWD. However, thermal, digital, and signal-averaging ECG systems have been used 
to evaluate PWD which was measured manually either on paper or on a high-resolution computer 
screen.  Although, several studies have demonstrated a low error of the measurement of P wave 
dispersion on paper printed ECGs [28,7]  others suggested that manual PWD measurement on 
paper printed ECGs obtained at a standard signal size and paper speed may have a questionable 
accuracy and reproducibility [37].                                                                                           
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Conclusions
Hyperthyroidism is associated with prolonged P wave duration and dispersion. Achievement of 
euthyroid state with PTU treatment results in shortening of P wave variables. Diastolic function 
may have a partial effect for the increased Pmax and PWD.  However, there is need for larger 
prospective studies to elucidate the role of P wave disturbances in prediction and early treatment 
of AF in hyperthyroid patients.                                                                                      
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